Jump Financial’s Standard BioTools LAB Stock Holding History

Jump Financial’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23,700	Closed	-$25.6K	–	1982
2025 Q1	$25.6K	Buy	+23,700	New	+$33.3K	﹤0.01%	1530
2024 Q2	–	Sell	-211,893	Closed	-$574K	–	2048
2024 Q1	$574K	Buy	211,893 +141,413	+201%	+$341K	0.02%	1103
2023 Q4	$156K	Buy	70,480 +38,030	+117%	+$81.2K	0.01%	1611
2023 Q3	$94.1K	Buy	+32,450	New	+$84.9K	﹤0.01%	1682
2022 Q3	–	Sell	-12,399	Closed	-$20K	–	1776
2022 Q2	$20K	Buy	+12,399	New	+$30.7K	﹤0.01%	1539
2021 Q4	–	Sell	-10,600	Closed	-$70K	–	1567
2021 Q3	$70K	Sell	10,600 -26,700	-72%	-$176K	0.01%	1013
2021 Q2	$230K	Sell	37,300 -5,668	-13%	-$30.3K	0.02%	791
2021 Q1	$194K	Buy	42,968 +31,389	+271%	+$172K	0.02%	767
2020 Q4	$69K	Buy	+11,579	New	+$76.1K	0.01%	890

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Jump Financial's LAB Position: Q2 2025 in Review

Jump Financial sold out of Standard BioTools (LAB) in Q2 2025, closing a stake of 23,700 shares — an estimated $25.6K sold.

Jump Financial first reported a position in LAB in Q4 2020 and held it in 9 quarters. The position peaked at $574K in Q1 2024. 160 funds tracked by Wall St. Rank hold LAB as of Q2 2025.

Jump Financial reported no remaining Standard BioTools position as of Q2 2025 after selling out during the quarter.
Jump Financial sold 23,700 Standard BioTools shares in Q2 2025, an estimated $25.6K.
Jump Financial first reported a position in Standard BioTools in Q4 2020 and held it in 9 quarters.
Jump Financial's Standard BioTools position peaked at $574K in Q1 2024.
160 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2025.

Based on Jump Financial's 13F filing for Q2 2025, filed 13 Aug 2025.